Location History:
- Woodside, NY (US) (2011)
- Flushing, NY (US) (2012)
Company Filing History:
Years Active: 2011-2012
Title: Innovations in Cancer Therapy by Inventor Jen-Chieh Tseng
Introduction
Jen-Chieh Tseng is a notable inventor based in Flushing, NY (US), recognized for his contributions to cancer therapy. He holds two patents that focus on innovative methods for treating and detecting cancer. His work is significant in the field of oncology, particularly in utilizing viral vectors for therapeutic purposes.
Latest Patents
One of his latest patents is titled "Tumor therapy with replication competent sindbis viral vectors." This patent discloses methods for treating mammals with solid tumors that express higher levels of High Affinity Laminin Receptors (LAMR) than normal cells. The method involves systematically administering a therapeutically effective amount of a Replication Competent (RC) Sindbis virus vector that encodes a suicide gene. Another important patent is "Method for detecting cancer cells and monitoring cancer therapy." This patent outlines methods for identifying cancer cells and monitoring anti-cancer therapy in mammals by delivering Sindbis viral vectors. The vector specifically targets and identifies tumor cells in various locations, demonstrating the remarkable specificity and safety of the Sindbis vector system.
Career Highlights
Jen-Chieh Tseng is affiliated with New York University, where he continues to advance his research in cancer therapies. His innovative approaches have the potential to significantly impact cancer treatment and detection.
Collaborations
He collaborates with Daniel Meruelo, contributing to the development of advanced cancer therapies.
Conclusion
Jen-Chieh Tseng's work exemplifies the intersection of innovation and healthcare, particularly in the fight against cancer. His patents reflect a commitment to improving treatment methodologies and enhancing patient outcomes.